Literature DB >> 7587992

Risk:benefit analysis of drugs in practice. The doctor, the patient and the licensing authority.

.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7587992     DOI： 10.1136/dtb.1995.33533

Source DB:  PubMed          Journal:  Drug Ther Bull        ISSN： 0012-6543


× No keyword cloud information.
  1 in total

Review 1.  Clinical endpoints in trials of drugs for cancer: time for a rethink?

Authors:  P P Koopmans
Journal:  BMJ       Date:  2002-06-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.